What Are the Difficulties in Conducting Randomised Controlled Trials of Thromboprophylaxis in Myeloma Patients and How Can We Address These? Lessons From Apixaban Versus LMWH or Aspirin as Thromboprophylaxis in Newly Diagnosed Multiple Myeloma (TiMM) Feasibility Clinical Trial
Journal of Thrombosis and Thrombolysis - Netherlands
doi 10.1007/s11239-019-01891-0
Full Text
Open PDFAbstract
Available in full text
Date
June 5, 2019
Authors
Publisher
Springer Science and Business Media LLC